Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-130962
Filing Date
2024-12-20
Accepted
2024-12-20 21:30:09
Documents
1
Period of Report
2024-12-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2431781-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2431781-1_4seq1.xml 4 4175
  Complete submission text file 0001104659-24-130962.txt   5641
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Issuer) CIK: 0001651407 (see all company filings)

EIN.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address
GRAY WILLIAM GARRETT (Reporting) CIK: 0001692961 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38128 | Film No.: 241569519